MedPath

An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System

Not Applicable
Terminated
Conditions
Non Small Cell Lung Cancer
4D CT
Interventions
Radiation: Stereotactic Radiosurgery
Registration Number
NCT02067858
Lead Sponsor
Steven Burton
Brief Summary

The goals of this clinical research are to evaluate the outcomes and tumor response for early stage non-small lung cancer (NSCLC) patients undergoing Stereotactic Body Radiation Therapy (SBRT) using four dimensional (4D) Positron Emission Tomography (PET) and Computed Tomography (CT), Cone-Beam Computed Tomography (CBCT), Real-Time Position Management (RPM™) and body immobilization system (see figure 1). Specifically, the effect of image-guided SBRT treatment on clinical tumor response rate, local control and progression-free survival will be studied. This study will examine target volumes and relevant margins determined by an assessment using 4D PET and repeated 4D CT. These data will allow us to evaluate and determine the impact of the body immobilization system on the planning target volume (PTV) margins, patient's breathing pattern, target motion, and inter-treatment targets shifts.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Stereotactic RadiosurgeryStereotactic Radiosurgery3 fractions x 20 Gy 4 fractions x 12 Gy Lesion dependent
Primary Outcome Measures
NameTimeMethod
Assess Clinical Response Rate and Local Control Following SBRT Treatment of Patients With Early Stage NSCLC2 years

The Number of Patients that completed SBRT

Secondary Outcome Measures
NameTimeMethod
Assess Progression-free Survival2 years

Number of patients with Progression Free Survival at 2 Years

Trial Locations

Locations (1)

UPMC Shadyside Radiation Oncology Department

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath